Christoph Westphal
Overview
Christoph Westphal received an average of $1M in total compensation, including $423K in salary, at Flex Pharma from 2014 to 2016. Christoph Westphal also received $7M at Verastem in 2012.
Source: SEC filings on April 19, 2017, April 28, 2016, and April 7, 2014.
Related executives
We found 17 more executives who work or worked at Flex Pharma and Verastem.
Daniel Paterson
Verastem
Chief Executive Officer
Brian Stuglik
Verastem
Chief Executive Officer
Daniel Calkins
Verastem
Chief Financial Officer
David and
Flex Pharma
Chief Executive Officer
Mark Rosenblum
Flex Pharma
Chief Financial Officer
Robert Gagnon
Verastem
Former Chief Business and Financial Officer
David Arthur
Flex Pharma
Chief Executive Officer
Robert Forrester
Verastem